Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.15 | 0.004 |